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 A 76-year-old man developed superior vena cava syndrome 
(SVCS) 20 months after the implantation of a dual chamber 
pacemaker, and was successfully treated with thrombolytic 
therapy followed by long-term anticoagulant therapy. The 
face and neck were markedly swollen, and superficial veins 
in the neck, upper arms and upper chest were prominently 
distended. Venography from bilateral cubital veins revealed 
a severe stenosis of the distal segment of the superior vena 
cava without the development of collateral channels. After an 
initial treatment with urokinase for 5 days followed by 
warfarin for 16 months, the symptoms and signs of the SVCS 
disappeared, and the digital subtraction angiography 
revealed a marked regression of the thrombotic stenosis. In 
view of the expected increase in the insertion of multiple leads 
in cases of dual chamber pacemakers or including fractured 
lead retention, more attention should be paid to the risk of 
the development of the SVCS in these cases.
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Introduction 
 Superior vena cava syndrome (SVCS) following trans-
venous pacemaker implantation is a rare complication. In 
recent years, A-V synchronous pacemakers with multiple 
leads (DDD or VDD mode) have been increasingly used for 
the treatment of disturbances of cardiac conduction and 
rhythm, because these type of pacemaker have the benefits 
of physiological pacing. Apart from new pacemaker 
implantations, recently due to the failure of previously 
implanted leads, the number of cases of new lead insertion 
has also increased. To date, several cases of SVCS follow-
ing the implantation of a pacemaker with multiple leads 
have been reported. We describe an additional case of 
SVCS 20 months after the implantation of a dual chamber 
pacemaker (DDD mode), and we review the previous 
reports on SVCS regarding the number of pacemaker leads, 
therapy and prognosis.
Case report 
 A 76-year-old man began to complain of general fatigue 
during mild effort in January, 1988. He was diagnosed as 
having a 2 : 1 A-V block and was admitted to our institu-
tion in April, 1988. The subsequently performed electro-
physiologic study revealed a H-V block, as a result of 
which a dual chamber pacemaker (Model 7008, Medtronic, 
Inc., Mineapolis, MN, USA) was implanted. An atrial lead 
(Model 4512, Medtronic) and ventricular lead (Model 
4012S, Medtronic) were inserted through the left sub-
clavian vein. The postoperative course was uncomplicated. 
The patient was discharged with the dual chamber pace-
maker (DDD mode) showing A-V sequential pacing. The 
outpatient clinic follow up was also uneventful. However, 
20 months after the pacemaker implantation in December 
1989, the patient developed swelling of face and neck and 
distension of superficial veins of neck and upper chest, 
suggesting the occurrence of SVCS. The patient was 
readmitted to the hospital in January 1990, because the 
swelling of face and neck had increased. On admission, the 
pulse was 60/min, and regular. Blood pressure was 148/86 
mmHg, and the temperature was 36.51C. Face and neck 
were markedly swollen and the skin in these areas was 
slightly cyanotic. Superficial veins in neck, upper arms and 
the upper chest were markedly distended. The heart was 
not enlarged. A grade 2 systolic ejection murmur was 
heard at the cardiac apex. The lungs were clear. Liver and 
spleen were not palpable. There was no pretibial edema. 
The neurological examination was negative. An electrocar-
diogram showed a stable pacemaker rhythm with A-V 
sequential pacing. A chest X-ray revealed the heart to be of 
normal size with a cardiothoracic ratio of 48%, normal 
vascular marking in the lung fields and no abnormal 
shadow suggesting a mediastinal tumor. Two pacemaker 
leads were seen in the superior vena cava extending toward 
the right atrium and right ventricle. The computed 
tomography (CT) scan of the chest and the echocardio-
gram were unremarkable. Peripheral venous pressures 
measured simultaneously at bilateral cubital veins were 
elevated to a level of 27 cm H20, suggesting the presence of
Fig. 1. Venography from bilateral cubital veins taken 
before treatment shows a severe stenosis of the distal segment 
of the SVC (arrow). The innominate veins and proximal 
portions of the subclavian veins are distended. Collaterals 
are not visible.
having SVCS caused by thrombotic stenosis of the distal 
segment of the SVC following the implantation of 
transvenous dual chamber pacemaker. 
 Urokinase (240,000 IU) was administered for 5 days 
followed by anticoagulant therapy with warfarin (2 to 3 
mg/days). The symptoms and signs improved to some 
extent and the peripheral venous pressure of the left 
cubital vein was reduced to 17.5 cm H20 in 2 weeks. 
However, approximately 4 weeks after the beginning of the 
thrombolytic and subsequent anticoagulant therapies, a 
clinical aggravation was observed and the peripheral 
venous pressure of the left cubital vein got elevated to 
24 cm H20. Warfarin was withdrawn, and urokinase 
(240,000 IU) was administered for 5 days. Then, warfarin 
(3 to 4 mg/day) was reinstituted. Three weeks after the 
reinstitution a slight improvement in the clinical condition 
was noted and the peripheral venous pressure was reduced 
to 22 cm H20. Pulmonary perfusion scintigraphy and 
pulmonary ventilation scintigraphy were performed, but 
they failed to reveal any dissociation between pulmonary 
ventilation and perfusion. The patient was discharged on 
warfarin (3 mg/day). 
 During the follow up period at the outpatient clinic, the 
swelling of the face and neck and the distension of the 
superficial veins in the neck, upper arms and upper chest 
was gradually reduced and disappeared completely 13 
months after discharge. Digital subtraction angiography 
of the SVC was performed in June 1991, 14 months after 
discharge. A marked regression of the thrombotic stenosis 
of the distal segment of the SVC without a collateral flow 
was observed (Fig. 2). To date, no recurrence of SVCS has 
been observed.
Fig. 2. The digital subtraction angiogram of the SVC from 
bilateral cubital veins, taken 16 months after the beginning of 
treatment shows a marked regression of the thrombotic 
stenosis of the SVC without collaterals.
severe stenosis or obstruction of the superior vena cava 
(SVC). 
 Hematological and biochemical tests revealed no signifi-
cant abnormalities. Coagulation parameters and fibri-
nolytic activity suggested thrombus formation, but 
absence of hematological disease responsible for thrombo-
sis. The prothrombin time was 11.6 sec with a control of 
11.2 sec. The platelet count was 120,000/cubic mm. The 
fibrinogen level was 282.3 mg/dl (normal, 168.3 to 328.8 
mg/dl) and fibrin degradation products were 3.7p g/ml. 
 A venography from bilateral cubital veins revealed a 
severe stenosis of the distal segment of the SVC without a 
development of significant collateral channels (Fig. 1). 
Based on these findings, the patient was diagnosed as
Discussion 
 Up to the present, many cases of SVCS following 
transvenous pacemaker implantation have been reported. 
Over the previous 27 years, more than 39 reports' of 
SVCS following pacemaker implantation have been pub-
lished. These reports are of 52 cases, 32 males and 18 
females ; in 2 cases the sex of the subjects was not re-
ported. The SVCS developed between 1 day and 17 years 
after the initial implantation of transvenous pacemaker, 
and between 1 week and 12 years after the last renewal of 
lead followed by withdrawal or retaining of the failed 
lead. 
 As for the possible causes of the development of SVCS, 
in 6 cases it was the developement of an infection via the 
pacemaker generator or pacing lead, in 1 case it was 
radiation therapy for thyroid cancer, in 1 case there was a 
compression of the SVC by an aortic aneurysm, and there 
was 1 case of cardiac involvement by non-Hodgkin's 
lymphoma. No particular cause was detected in the re-
maining 43 cases.
  Venography revealed obstruction or stenosis of the SVC 
and obstruction of the other veins such as innominate, 
subclavian and jugular veins. 
  Generally, SVCS due to transvenous pacing lead inser-
tion is a rare event. Goudvenous et al'). observed one case 
of SVCS out of 3,100 primary pacemaker implantations. 
However, Stoney et a140'. reported that venographic abnor-
malities indicating thrombus formation were seen in most 
cases of transvenous pacemaker implantation, but the 
incidence of clinical symptoms and signs such as facial 
edema was very low. 
 Since 1969, the SVCS was reported in 26 cases with a 
single lead and in 26 cases with 2 or more leads including 
retained leads. However, if only the data after 1980 are 
considered, it is seen that SVCS was reported in 12 cases 
with a single lead and in 24 cases with 2 or more leads. 
Paulleti et al"). reported that venographic abnormalities 
representing thrombus formation caused by the pacemaker 
lead were more prominent in patients with multiple leads 
than in patients with a single lead. Based on this literature 
review, it may be assumed that patients with multiple 
pacing leads may have a tendency to developed SVCS more 
frequently than patients with a single lead. 
 The reported treatment regimens of SVCS included 
anticoagulant therapy with heparin or urokinase in the 
majority of the reported cases. Recanalization of the 
obstructed site was confirmed by venography in 8 of 10 
cases with thrombolytic therapy followed by anticoagu-
lant therapy but in none of 13 cases with anticoagulant 
therapy only. Seven cases were treated surgically. Nine 
cases successfully treated recently with percutaneous 
transluminal balloon angioplasty of the SVC, and in one 
case, this was followed by venous stenting'). Among the 52 
cases reported to date, death occured in 5 early cases that 
were not treated with anticoagulant or thrombolytic 
therapy, whereas in 47 cases in which proper treatment 
was applied without delay, improvement or disappearance 
of the symptoms and signs was reported. Thus, the prog-
nosis of this syndrome seems to be relatively good in case 
of an appropriate treatment. 
 In the present case no particular cause for the develop-
ment of SVCS, such as an infection via the pacemaker 
system or mediastinal tumor, could be identified. It seems 
likely that the transvenous insertion of 2 pacing leads 
promoted a thrombus formation and was involved in the 
development of SVCS. In this patient, the SVCS was 
relieved with long-term anticoagulant therapy following 
intravenous thrombolytic therapy with urokinase. It seems 
that immediate thrombolytic and anticoagulant therapy 
should be a. first choice of treatment, but surgical treat-
ment or angioplasty should be performed without delay 
when conservative treatment is unsuccessful. In view of the 
expected increase in the insertion of multiple leads includ-
ing the retention of fractured lead, close attention should 
be paid to the risk of the development of SVCS in patients
with multiple pacemaker leads.
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